Yang Qu
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Renal cell carcinoma treatment 12
- Lung Cancer Diagnosis and Treatment 4
- Lung Cancer Treatments and Mutations 4
- Oncology 17
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Jianming Guo (24 shared papers)Li Liu (25 shared papers)Ying Xiong (24 shared papers)Yu Xia (21 shared papers)Qi Bai (21 shared papers)Jiejie Xu (22 shared papers)Gang Zhao (1 shared paper)Hui Li (1 shared paper)
- Journals
- Oncotarget (7 papers)OncoImmunology (4 papers)Urologic Oncology Seminars and Original Investigations (3 papers)Coronary Artery Disease (2 papers)Cancer Immunology Immunotherapy (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Yang Qu
53 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 78
- Immunology 254
- Oncology 275
- Pulmonary and Respiratory Medicine 304
- Cancer Research 102
- Molecular Biology 233
Countries citing papers authored by Yang Qu
This map shows the geographic impact of Yang Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Qu more than expected).
Fields of papers citing papers by Yang Qu
This network shows the impact of papers produced by Yang Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Qu. The network helps show where Yang Qu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 145 | |
| 2 | 2018 | 85 | |
| 3 | 2021 | 77 | |
| 4 | 2017 | 76 | |
| 5 | 2018 | 48 | |
| 6 | 2019 | 40 | |
| 7 | 2020 | 40 | |
| 8 | 2016 | 38 | |
| 9 | 2018 | 37 | |
| 10 | 2015 | 31 | |
| 11 | 2018 | 31 | |
| 12 | 2014 | 29 | |
| 13 | 2016 | 23 | |
| 14 | 2018 | 21 | |
| 15 | 2016 | 16 | |
| 16 | 2015 | 15 | |
| 17 | 2015 | 15 | |
| 18 | 2016 | 15 | |
| 19 | 2014 | 14 | |
| 20 | 2018 | 14 |
About Yang Qu
Yang Qu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Surgery and Molecular Biology, having authored 54 papers that have together received 1.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (12 papers), Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Diagnosis and Treatment (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cardiac, Anesthesia and Surgical Outcomes (3 papers), Renal and related cancers (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Immunology (254 citations), Oncology (275 citations), Pulmonary and Respiratory Medicine (304 citations), Cancer Research (102 citations) and Molecular Biology (233 citations). Yang Qu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jianming Guo, Li Liu, Ying Xiong, Yu Xia, Qi Bai, Jiejie Xu, Gang Zhao, Hui Li, Jinggang Xia and Zhiyuan Lin. Their work appears in journals such as Oncotarget, OncoImmunology, Urologic Oncology Seminars and Original Investigations, Coronary Artery Disease and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.